🇺🇸 FDA
Pipeline program

mRNA-3927

mRNA-3927-P101-EXT

Phase 2 small_molecule active

Quick answer

mRNA-3927 for Propionic Acidemia is a Phase 2 program (small_molecule) at Moderna Biotech Spain with 1 ClinicalTrials.gov record(s).

Program details

Company
Moderna Biotech Spain
Indication
Propionic Acidemia
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials